Recent developments in the field of antitumour anthracyclines

Eur J Med Chem. 2001 Jun;36(6):483-93. doi: 10.1016/s0223-5234(01)01244-2.
No abstract available

Publication types

  • Review

MeSH terms

  • Aclarubicin / adverse effects
  • Aclarubicin / analogs & derivatives
  • Aclarubicin / pharmacology
  • Aclarubicin / therapeutic use
  • Amino Acid Sequence
  • Animals
  • Anthracyclines / adverse effects
  • Anthracyclines / chemical synthesis
  • Anthracyclines / chemistry*
  • Anthracyclines / pharmacology*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology*
  • Carubicin / analogs & derivatives
  • Carubicin / pharmacology
  • Daunorubicin / adverse effects
  • Daunorubicin / analogs & derivatives
  • Daunorubicin / pharmacology
  • Daunorubicin / therapeutic use
  • Doxorubicin / adverse effects
  • Doxorubicin / analogs & derivatives
  • Doxorubicin / pharmacology
  • Doxorubicin / therapeutic use
  • Drug Resistance, Neoplasm
  • Humans
  • Neoplasms / drug therapy*

Substances

  • Anthracyclines
  • Antineoplastic Agents
  • Aclarubicin
  • Doxorubicin
  • Carubicin
  • Daunorubicin